RICKEY GRAY: Open Payments
NPI 1194826677 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 14 payments from 6 companies in 2025. Trend: 2023 $237 · 2024 $92 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $136 |
| ABBVIE INC. | 1 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: ABILIFY MAINTENA, VRAYLAR, ABILIFY ASIMTUFII, INVEGA SUSTENNA, REXULTI, CAPLYTA, INGREZZA.
Industry payments across AR — which companies pay providers there.
